Stem cell therapy helps reduce insulin use in type 1 diabetes
Medscape - 15-Jul-2024No severe issues came from the therapy itself, just the procedure or immunosuppression
Join the club for FREE to access the whole archive and other member benefits.
Medical journalist
Miriam E. Tucker is a dedicated medical journalist with a passion for reporting on diabetes. Living with type 1 diabetes since 1973, she has been writing about the condition professionally since 1986. Over the years, she has contributed extensively to Medscape and various other publications, covering topics such as cardiology, cancer, and public health. Miriam’s work is recognized for its clarity and accuracy, earning her respect in the medical journalism community. Her contributions to diabetes awareness and healthcare reporting have made her a valuable resource in the field. She also enjoys exploring topics that offer new insights.
Medscape provides breaking medical news and expert perspectives, drug and disease information
Details last updated 15-Oct-2024
No severe issues came from the therapy itself, just the procedure or immunosuppression